Silverback Therapeutics to merge with San Diego biotech company developing EpiPen alternative by Charlotte Schubert on July 21, 2022August 4, 2022 at 2:59 pm Less than two years after its IPO and months after shutting down its once-promising oncology program, Seattle-based Silverback Therapeutics will merge with another biotech company, San Diego-based ARS Pharmaceuticals. The… Read More